Siegel RL, Miller KD, Jemal A. Cancer statistics, 2017. CA Cancer J Clin. 2017;67:7–30.

Article  PubMed  Google Scholar 

Zarour LR, Anand S, Billingsley KG, Bisson WH, Cercek A, Clarke MF, et al. Colorectal cancer liver metastasis: evolving paradigms and future directions. Cell Mol Gastroenterol Hepatol 2017;3:163–73.

Article  PubMed  PubMed Central  Google Scholar 

Manfredi S, Lepage C, Hatem C, Coatmeyr O, Faivre J, Bouvier A. Epidemiology and management of liver metastases from colorectal cancer. Ann Surg 2006;244:254–9.

Article  PubMed  PubMed Central  Google Scholar 

Leith JT, Padfield G, Faulkner L, Michelson S. Hypoxic fractions in xenografted human colon tumors. Cancer Res. 1991;51:5139–43.

CAS  PubMed  Google Scholar 

Semenza GL. Hypoxia-inducible factors in physiology and medicine. Cell. 2012;148:399–408.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Thiery JP, Acloque H, Huang RYJ, Nieto MA. Epithelial-mesenchymal transitions in development and disease. Cell. 2009;139:871–90.

Article  CAS  PubMed  Google Scholar 

De Bock K, Mazzone M, Carmeliet P. Antiangiogenic therapy, hypoxia, and metastasis: risky liaisons, or not? Nat Rev Clin Oncol 2011;8:393.

Article  PubMed  Google Scholar 

Kalluri R, Weinberg RA. The basics of epithelial-mesenchymal transition. J Clin Investig 2009;119:1420–8.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Zeisberg M, Neilson EG. Biomarkers for epithelial-mesenchymal transitions. J Clin Investig 2009;119:1429–37.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Wang GL, Semenza GL. General involvement of hypoxia-inducible factor 1 in transcriptional response to hypoxia. Proc Natl Acad Sci USA. 1993;90:4304–8.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Ravenna L, Salvatori L, Russo MA. HIF3α: the little we know. FEBS J. 2016;283:993–1003.

Article  CAS  PubMed  Google Scholar 

Zhong H, De Marzo AM, Laughner E, Lim M, Hilton DA, Zagzag D, et al. Overexpression of hypoxia-inducible factor 1α in common human cancers and their metastases. Cancer Res. 1999;59:5830–5.

CAS  PubMed  Google Scholar 

Imamura T, Kikuchi H, Herraiz M, Park D, Mizukami Y, Mino-Kenduson M, et al. HIF-1alpha and HIF-2alpha have divergent roles in colon cancer. Int J Cancer. 2009;124:763–71.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Nagaraju GP, Bramhachari PV, Raghu G, El-Rayes BF. Hypoxia inducible factor-1α: Its role in colorectal carcinogenesis and metastasis. Cancer Lett. 2015;366:11–18.

Article  CAS  PubMed  Google Scholar 

Chen Z, He X, Xia W, Huang Q, Zhang Z, Ye J, et al. Prognostic value and clinicopathological differences of HIFs in colorectal cancer: evidence from meta-analysis. PLoS ONE. 2013;8:e80337.

Article  PubMed  PubMed Central  Google Scholar 

Li H, Rokavec M, Jiang L, Horst D, Hermeking H. Antagonistic effects of p53 and HIF1A on microRNA-34a regulation of PPP1R11 and STAT3 and hypoxia-induced epithelial to mesenchymal transition in colorectal cancer cells. Gastroenterology. 2017;153:505–20.

Article  CAS  PubMed  Google Scholar 

Xue X, Taylor M, Anderson E, Hao C, Qu A, Greenson JK, et al. Hypoxia-inducible factor-2alpha activation promotes colorectal cancer progression by dysregulating iron homeostasis. Cancer Res. 2012;72:2285–93.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Xue X, Ramakrishnan SK, Shah YM. Activation of HIF-1α does not increase intestinal tumorigenesis. Am J Physiol Gastrointest Liver Physiol 2014;307:G187–95.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Xue X, Jungles K, Onder G, Samhoun J, Győrffy B, Hardiman K. HIF-3α1 promotes colorectal tumor cell growth by activation of JAK-STAT3 signaling. Oncotarget. 2016;7:11567–79.

Article  PubMed  PubMed Central  Google Scholar 

Morales M, Xue X. Targeting iron metabolism in cancer therapy. Theranostics. 2021;11:8412–29.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Kim H, Villareal LB, Liu Z, Haneef M, Falcon DM, Martin DR, et al. Transferrin receptor-mediated iron uptake promotes colon tumorigenesis. Adv Sci. 2023;10:2207693.

Article  CAS  Google Scholar 

Schwartz AJ, Goyert JW, Solanki S, Kerk SA, Chen B, Castillo C, et al. Hepcidin sequesters iron to sustain nucleotide metabolism and mitochondrial function in colorectal cancer epithelial cells. Nat Metab 2021;3:969–82.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Mehta KJ, Sharp PA. Iron elevates mesenchymal and metastatic biomarkers in HepG2 cells. Sci Rep. 2020;10:21926.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Xue X, Ramakrishnan S, Weisz K, Triner D, Xie L, Győrffy B, et al. Iron uptake via DMT1 integrates cell cycle with JAK-STAT3 signaling to promote colorectal tumorigenesis. Cell Metab. 2016;24:447–61.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Triner D, Xue X, Schwartz AJ, Jung I, Colacino JA, Shah YM. Epithelial hypoxia-inducible factor 2α facilitates the progression of colon tumors through recruiting neutrophils. Mol Cell Biol. 2017;37:e00481–16.

Article  PubMed  PubMed Central  Google Scholar 

Yin K, Lee J, Liu Z, Kim H, Martin DR, Wu D, et al. Mitophagy protein PINK1 suppresses colon tumor growth by metabolic reprogramming via p53 activation and reducing acetyl-CoA production. Cell Death Differ. 2021;28:2421–35.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Beltran M, Puig I, Peña C, García JM, Alvarez AB, Peña R, et al. A natural antisense transcript regulates Zeb2/Sip1 gene expression during Snail1-induced epithelial-mesenchymal transition. Genes Dev 2008;22:756–69.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Xue X, Ramakrishnan S, Anderson E, Taylor M, Zimmermann EM, Spence JR, et al. Endothelial PAS domain protein 1 activates the inflammatory response in the intestinal epithelium to promote colitis in mice. Gastroenterology. 2013;145:831–41.

Article  CAS  PubMed  Google Scholar 

Jędroszka D, Orzechowska M, Hamouz R, Górniak K, Bednarek AK. Markers of epithelial-to-mesenchymal transition reflect tumor biology according to patient age and Gleason score in prostate cancer. PLoS ONE. 2017;12:e0188842.

Article  PubMed  PubMed Central  Google Scholar 

Higgins DF, Kimura K, Bernhardt WM, Shrimanker N, Akai Y, Hohenstein B, et al. Hypoxia promotes fibrogenesis in vivo via HIF-1 stimulation of epithelial-to mesenchymal transition. J Clin Investig 2007;117:3810–20.

CAS  PubMed  PubMed Central  Google Scholar 

Zhang W, Shi X, Peng Y, Wu M, Zhang P, Xie R, et al. HIF-1α promotes epithelial-mesenchymal transition and metastasis through direct regulation of ZEB1 in colorectal cancer. PLoS ONE. 2015;10:e0129603.

Article  PubMed  PubMed Central  Google Scholar 

Bartha Á, Győrffy B. TNMplot.com: a web tool for the comparison of gene expression in normal, tumor and metastatic tissues. Int J Mol Sci. 2021;22:2622.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Soares KC, Foley K, Olino K, Leubner A, Mayo SC, Jain A, et al. A preclinical murine model of hepatic metastases. J Vis Exp. 2014; https://doi.org/10.3791/51677.

Wang Y, Yu L, Ding J, Chen Y. Iron metabolism in cancer. Int J Mol Sci. 2018;20:95.

Article  PubMed  PubMed Central  Google Scholar 

Bhutia YD, Ogura J, Grippo PJ, Torres C, Sato T, Wachtel M, et al. Chronic exposure to excess iron promotes EMT and cancer via p53 loss in pancreatic cancer. Asian J Pharm Sci. 2020;15:237–51.

Article  PubMed  PubMed Central  Google Scholar 

Bianchi L, Tacchini L, Cairo G. HIF-1-mediated activation of transferrin receptor gene transcription by iron chelation. Nucleic Acids Res. 1999;27:4223–7.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Fang H-Y, Hughes R, Murdoch C, Coffelt SB, Biswas SK, Harris AL, et al. Hypoxia-inducible factors 1 and 2 are important transcriptional effectors in primary macrophages experiencing hypoxia. Blood. 2009;114:844–59.